Clinical Report: Atrial Tachycardia During Ablation of Paroxysmal Atrial Fibrillation
Overview
Intra-procedural atrial tachycardia (IAT) occurred in 13.33% of patients undergoing RFCA for paroxysmal atrial fibrillation (PAF). Right atrial enlargement was identified as a significant risk factor, but successful management of IAT can lead to similar long-term outcomes as those without IAT.
Background
Radiofrequency catheter ablation (RFCA) is a key treatment for paroxysmal atrial fibrillation (PAF), yet the occurrence of intra-procedural atrial tachycardia (IAT) during this procedure is not well understood. Understanding the incidence and mechanisms of IAT is crucial for improving procedural outcomes and patient management. This study aims to clarify the frequency, risk factors, and clinical implications of IAT during PAF ablation.
Data Highlights
Parameter
Value
IAT Incidence
13.33%
Right Atrial Enlargement Odds Ratio
1.14 (P = 0.015)
12-Month Sinus Rhythm Maintenance Rate
78.0%
AT Group Maintenance Rate
79.4%
Non-AT Group Maintenance Rate
77.8%
Key Findings
IAT occurred in 13.33% of patients undergoing RFCA for PAF.
Right atrial enlargement was identified as an independent risk factor for IAT.
The primary mechanisms of IAT were macro-reentrant circuits around the tricuspid and mitral annuli.
12-month sinus rhythm maintenance rates were similar between IAT and non-IAT groups.
Successful identification and ablation of IAT can lead to favorable long-term outcomes.
Clinical Implications
Clinicians should be aware of the risk of IAT during RFCA for PAF, particularly in patients with right atrial enlargement. Prompt identification and targeted ablation of IAT can improve long-term outcomes, making it a manageable complication rather than a predictor of failure.
Conclusion
IAT is a notable occurrence during PAF ablation, but with appropriate management, patients can achieve outcomes comparable to those without IAT. This highlights the importance of monitoring and addressing IAT during procedures.
